iTeos Therapeutics
ITOS
#7332
Rank
$0.30 B
Marketcap
$8.45
Share price
-1.63%
Change (1 day)
-9.72%
Change (1 year)

Operating Margin for iTeos Therapeutics (ITOS)

Operating Margin as of October 2024 (TTM): -26.73%

According to iTeos Therapeutics's latest financial reports and stock price the company's current Operating Margin is -26.73%. At the end of 2023 the company had an Operating Margin of -865.66%.

Operating Margin history for iTeos Therapeutics from 2022 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-865.66%-1657.64%
202255.58%-25.29%
202174.39%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.